Here"s Why Aurinia Pharmaceuticals Inc. Gained 32.2% in the First Half of 2018
What happened Shares of Aurinia Pharmaceuticals Inc NASDAQ AUPH 160 a clinical stage biotechnology company gained 32 2 in the first half of 2018 according to data from S amp P Global Market Intelligence Investors anticipating success with the company s.....»»
Here"s Why Rigel Pharmaceuticals Gained 17.3% in March
The pharma company announced full-year 2018 operating results......»»
Aurinia Pharmaceuticals Inc (AUPH) Q4 2018 Earnings Conference Call Transcript
AUPH earnings call for the period ending December 31, 2018......»»
Aurinia Pharmaceuticals, Inc. (AUPH) CEO Dr. Richard Glickman on Q4 2018 Results - Earnings Call Transcript
Aurinia Pharmaceuticals, Inc. (AUPH) CEO Dr. Richard Glickman on Q4 2018 Results - Earnings Call Transcript.....»»
Aurinia Pharmaceuticals (AUPH) Presents At 2018 Bloom Burton & Co. Healthcare Investor Conference - Slideshow
Aurinia Pharmaceuticals (AUPH) Presents At 2018 Bloom Burton & Co. Healthcare Investor Conference - Slideshow.....»»
Aurinia Pharmaceuticals" (AUPH) CEO Richard Glickman on Q1 2018 Results - Earnings Call Transcript
Aurinia Pharmaceuticals" (AUPH) CEO Richard Glickman on Q1 2018 Results - Earnings Call Transcript.....»»
Steven Cohen Keeps Buying Acadia Pharmaceuticals, a Stock Down by Half This Year
The FDA said it would re-examine the company's only drugCheck out Steven Cohen Stock Picks » Download GuruFolio Report of Steven Cohen (Updated on 06/19/2018)Related Stocks: ACAD,.....»»
Analyst Says Nvidia"s Second-Half Outlook Is Promising
NVIDIA Corporation (NASDAQ: NVDA) stock has gained another 24.7 percent so far in 2018, but one analyst’s recent mid-quarter channel checks revealed Nvidia is showing no signs of slowing down. Latest Ratings for NVDA D.....»»
Why Akamai Technologies, Inc. Stock Gained 12.6% in the 1st Half of 2018
The content delivery expert brought in an activist investor firm to boost operating margins and start exploring strategic options. Investors were quick to embrace these ideas......»»
Why World Wrestling Entertainment, Inc. Stock Soared 138.1% in the First Half of 2018
What happened Shares of World Wrestling Entertainment NYSE WWE gained a whopping 138 1 through the first six months of the year according to data from S amp P Global Market Intelligence WWE data by YCharts The sports.....»»
Why Momo Inc. Stock Gained 77.7% in the First Half of 2018
Strong quarterly reports, a return to paid-user growth, and a big acquisition sent Momo stock soaring......»»
Aurinia Pharmaceuticals" (AUPH) CEO Richard Glickman on Q2 2018 Results - Earnings Call Transcript
Aurinia Pharmaceuticals" (AUPH) CEO Richard Glickman on Q2 2018 Results - Earnings Call Transcript.....»»
CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results
CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results - China FDA (CFDA) import drug re.....»»
2018 Is An Ideal Entry Point For Aurinia Pharmaceuticals
2018 Is An Ideal Entry Point For Aurinia Pharmaceuticals.....»»
Aurinia Pharmaceuticals" (AUPH) CEO Rich Glickman on Q3 2018 Results - Earnings Call Transcript
Aurinia Pharmaceuticals" (AUPH) CEO Rich Glickman on Q3 2018 Results - Earnings Call Transcript.....»»
Aurinia Pharmaceuticals: AURORA 1 Phase 3 study results published in The Lancet
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Inovio"s stock is up after it shares new data from Phase 2 clinical trial for its COVID-19 vaccine candidate
Shares of Inovio Pharmaceuticals Inc. gained 8.0% in premarket trading on Monday after the company said its experimental COVID-19 vaccine was safe and also triggered antibody titers in 400 or so adult participants in a P.....»»
Aurinia Pharmaceuticals price target lowered to $23 from $26 at RBC Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aurinia Pharmaceuticals reports Q1 EPS (40c), consensus (14c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»